Complication rates are low with the use of Stimulan calcium sulphate based antibiotic delivery system in the management of patients with hip-related PJI: early results of a consecutive case series

Abstract

Background:

Effective management of prosthetic joint infection (PJI) requires prolonged, sustained delivery of antibiotics to the effective joint space. Calcium sulphate antibiotic delivery systems have been used in this setting, however, potentially serious complications including symptomatic hypercalcaemia have been described. There is relatively little prospective data on the results with the use of these compounds.

Methods:

A prospective study was performed between October 2016 and June 2018. 29 patients who underwent revision total hip arthroplasty (THA) for confirmed PJI were treated with Stimulan calcium sulphate antibiotic delivery system. Laboratory blood tests including serum calcium levels, C-reactive protein (CRP) and white cell count (WBC) were monitored for 6 weeks post-surgery. Wounds were assessed for discharge and radiographs for dissolution and for signs of heterotopic ossification.

Results:

The mean age was 67 years and mean ASA score III. There was no significant increase between the preoperative serum calcium and those at 2 and 6 weeks. The CRP and white cell count were significantly reduced at 6 weeks. Full dissolution occurred by 6 weeks post-op. 1 patient (3.4%) had a prolonged wound discharge.

Conclusions:

Stimulan is a valid option for management of patients with PJI following total hip arthroplasty. Complication rates are low following its use.

Keywords

Arthroplasty hip infection PJI revision Stimulan

Get full access to this article

View all access options for this article.

References

Anagnostakos

Kelm

Enhancement of antibiotic elution from acrylic bone cement. J Biomed Mater Res B Appl Biomater 2009; 90: 467–475.

Penner

Masri

Duncan

CP.

Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996; 11: 939–944.

Lawson

Marks

Brems

, et al. Vancomycin vs tobramycin elution from polymethylmethacrylate: an in vitro study. Orthopedics 1990; 13: 521–524.

Kallala

Harris

Ibrahim

, et al. Use of Stimulan absorbable calcium sulphate beads in revision lower limb arthroplasty: safety profile and complication rates. Bone Joint Res 2018; 7: 570–579.

Kallala

Haddad

FS.

Hypercalcaemia following the use of antibiotic-eluting absorbable calcium sulphate beads in revision arthroplasty for infection. Bone Joint J 2015; 97–B: 1237–1241.

Parvizi

Zmistowski

Berbari

, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469: 2992–2994.

Dale

Fenstad

Hallan

, et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012; 83: 449–458.

Lenguerrand

Whitehouse

Beswick

, et al. Revision for prosthetic joint infection following hip arthroplasty: evidence from the National Joint Registry. Bone Joint Res 2017; 6: 391–398.

McKee

Li-Bland

Wild

, et al. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthop Trauma 2010; 24: 483–490.

10.

Lum

Pereira

GC.

Local bio-absorbable antibiotic delivery in calcium sulfate beads in hip and knee arthroplasty. J Orthop 2018; 15: 676–678.

11.

McPherson

Dipane

Sherif

SM.

Dissolvable antibiotic beads in treatment of periprosthetic joint infection and revision arthroplasty: the use of synthetic pure calcium sulfate (Stimulan^®) impregnated with vancomycin & tobramycin. Reconstr Rev 2013; 3: 32–43.